Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India · Delayed Price · Currency is INR 196.37
-15.74 (-7.42%)
Jun 1, 2026, 3:30 PM IST
NSE:SPARC Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 15,532 | -3,425 | -3,872 | -2,226 | -2,034 |
Depreciation & Amortization | 102.1 | 122.7 | 123.26 | 115.57 | 99.47 |
Other Amortization | - | 1.25 | 1.85 | 2.14 | 2.15 |
Loss (Gain) From Sale of Assets | 2.4 | -0.33 | -0.6 | 1.13 | -48.93 |
Loss (Gain) From Sale of Investments | - | -10.55 | -31.81 | -32.65 | -4.64 |
Provision & Write-off of Bad Debts | - | - | 20.5 | - | - |
Other Operating Activities | 621.6 | 177.71 | -259.6 | 37.39 | 164.11 |
Change in Accounts Receivable | 82.6 | -4.28 | 152.14 | -50.06 | -101.46 |
Change in Accounts Payable | -182.2 | -292.88 | -58.9 | 766.68 | -193.58 |
Change in Other Net Operating Assets | -18,546 | -171.46 | -366.58 | 694.47 | 34.51 |
Operating Cash Flow | -2,388 | -3,603 | -4,292 | -691.18 | -2,082 |
Capital Expenditures | -238.3 | -103.4 | -265.08 | -153.87 | -326.78 |
Sale of Property, Plant & Equipment | 3 | 5.95 | 4.85 | 4.65 | 81.02 |
Investment in Securities | - | 1,529 | 3,952 | -5,352 | -47.71 |
Other Investing Activities | 0.3 | 145.48 | 223.72 | 18.69 | 1.8 |
Investing Cash Flow | -235 | 1,577 | 3,915 | -5,483 | -291.67 |
Long-Term Debt Issued | 21,158 | 5,802 | 644.12 | 2,245 | 1,070 |
Total Debt Issued | 21,158 | 5,802 | 644.12 | 2,245 | 1,070 |
Long-Term Debt Repaid | -18,202 | -3,725 | -204.04 | -3,024 | -2,646 |
Net Debt Issued (Repaid) | 2,956 | 2,077 | 440.09 | -778.17 | -1,576 |
Issuance of Common Stock | - | - | - | 7,028 | 4,093 |
Other Financing Activities | -342.2 | -84.22 | -16.04 | -82.07 | -223.01 |
Financing Cash Flow | 2,614 | 1,993 | 424.05 | 6,168 | 2,293 |
Foreign Exchange Rate Adjustments | 0.8 | 0.12 | 0.02 | - | -0.02 |
Net Cash Flow | -8 | -33.66 | 47.46 | -6.41 | -80.8 |
Free Cash Flow | -2,626 | -3,706 | -4,557 | -845.05 | -2,409 |
Free Cash Flow Margin | -670.75% | -516.45% | -603.21% | -35.39% | -175.53% |
Free Cash Flow Per Share | -8.09 | -11.42 | -14.04 | -2.97 | -9.15 |
Cash Interest Paid | 342.2 | 84.22 | 16.04 | 82.07 | 142.18 |
Cash Income Tax Paid | -316.4 | -88.27 | 41.11 | -53.65 | -45.44 |
Levered Free Cash Flow | -8,950 | -1,261 | -2,931 | -611.54 | -1,833 |
Unlevered Free Cash Flow | -8,736 | -1,208 | -2,924 | -563.82 | -1,750 |
Change in Working Capital | -18,646 | -468.62 | -273.34 | 1,411 | -260.53 |